Post Holdings, Inc. reported second fiscal quarter ended March 31, 2024 results: revenue $2.0 billion, net income $97.2 million. Guidance raised.
“Inc. (NYSE:POST), a consumer packaged goods holding company, today reported results for the second fiscal quarter ended March 31, 2024. Highlights: • Second quarter net sales of $2.0 billion • Operating profit of $190.1 million; net earnings of $97.2 million and Adjusted EBITDA (non-GAAP)* of $345.2 million • Raised fiscal year 2024 Adjusted EBITDA (non-GAAP)*”
TROXTronox Holdings plc
Tronox Holdings plc updated its Second Quarter 2024 guidance (initiated).
“Second Quarter 2024 Outlook: • TiO 2 volumes expected to increase 7-10% compared to Q1 2024 • Zircon volumes expected to be relatively flat compared to Q1 2024 • Adjusted EBITDA expected to be $160-180 million and Adjusted EBITDA margin to be in the range of 20%”
TROXTronox Holdings plc
Tronox Holdings plc reported the first quarter ended March 31, 2024 results: revenue $774 million, net income net loss of $9 million, EPS GAAP diluted loss per share of $0.06.
“Produced revenue of $774 million, a 13% increase compared to the prior quarter, or a 9% increase compared to the prior year • Generated income from operations of $41 million , and a net loss of $9 million ; adjusted net loss was $7 million (non-GAAP) • GAAP diluted loss per share of $0.06 ; Adjusted diluted loss per share was $0.05 (non-GAAP)”
APTVAptiv PLC
Aptiv PLC reported Full Year 2024 results: EPS Adjusted net income per share $5.80 - $6.30. Guidance lowered.
“The Company’s full year 2024 financial guidance is as follows: (in millions, except per share amounts) Full Year 2024 Net sales $20,850 - $21,450 Adjusted EBITDA $3,150 - $3,300 Adjusted EBITDA margin 15.1% - 15.4% Adjusted operating income $2,425 - $2,575 Adjusted operating income margin 11.6% - 12.0% Adjusted net income per share (1) $5.80 - $6.30 Cash flow from operations $2,350 Capital expenditures $1,000 Adjusted effective tax rate ~17.5%”
APTVAptiv PLC
Aptiv PLC reported first quarter 2024 results: revenue U.S. GAAP revenue of $4.9 billion, net income U.S. GAAP net income of $218 million, EPS $0.79 per diluted share.
“of $0.79 per diluted share. Excluding special items, first quarter earnings totaled $1.16 per diluted share. First Quarter Financial Highlights Include : • U.S. GAAP revenue of $4.9 billion, an increase of 2% ◦ Revenue increased 2% adjusted for currency exchange and commodity movements; growth over market of 3% based on AWM 1 of (1)% • U.S. GAAP net income of $218”
APTVAptiv PLC
Aptiv PLC reported quarter ended March 31, 2024 results: revenue U.S. GAAP revenue of $4.9 billion, net income U.S. GAAP net income of $218 million, EPS $0.79 per diluted share.
“of $0.79 per diluted share. Excluding special items, first quarter earnings totaled $1.16 per diluted share. First Quarter Financial Highlights Include : • U.S. GAAP revenue of $4.9 billion, an increase of 2% ◦ Revenue increased 2% adjusted for currency exchange and commodity movements; growth over market of 3% based on AWM 1 of (1)% • U.S. GAAP net income of $218”
ATH-PAAthene Holding Ltd.
Athene Holding Ltd. reported financial results for first quarter ended March 31, 2024.
“On May 2, 2024, Apollo Global Management, Inc. issued an earnings presentation announcing its financial results for the first quarter ended March 31, 2024, which contained information regarding Athene Holding Ltd.’s financial results for the first quarter ended March 31, 2024.”
Pactiv Evergreen Inc.
Pactiv Evergreen Inc. reported first quarter of 2024 results: revenue $1,252 million, net income $10 million, EPS $0.04. Guidance reaffirmed.
“First Quarter 2024 Financial Results Solid operating performance despite macro challenges; Reiterating 2024 guidance First Quarter 2024 Financial Highlights: • Net Revenues of $1,252 million for the first quarter of 2024 were down 13% compared to $1,431 million in the first quarter of 2023 and down 2% compared to $1,274 million in the fourth quarter of 2023. • Net”
XYLXylem Inc.
Xylem Inc. reported the quarter ended March 31, 2024 results: revenue $2.0 billion, net income $153 million, EPS $0.63 per share. Guidance raised.
“Xylem Reports First Quarter 2024 Results and Raises Full-Year Guidance • Orders of $2.2 billion, up 43% on a reported basis and 3% organically • Revenue of $2.0 billion, up 40% on a reported basis and 7% organically • Earnings per share of $0.63, up 17%; $0.90 on an adjusted basis, up 14% • Raising full-year revenue guidance to approximately”
LNTHLantheus Holdings, Inc.
Lantheus Holdings, Inc. reported first quarter ended March 31, 2024 results: revenue $370.0 million, net income $131.1 million, EPS $1.87. Guidance raised.
“Lantheus Reports First Quarter 2024 Financial Results First Quarter 2024 • Worldwide revenue of $370.0 million, an increase of 23.0% from first quarter 2023 • GAAP fully diluted net income per share of $1.87, compared to GAAP fully diluted net loss per share of $0.04 in first quarter 2023. Adjusted fully diluted net income per share of $1.69 compared to adjusted fully diluted net income per share of $1.47 in the first quarter 2023 • The Company increases full year 2024 net revenue and earnings guidance and provides guidance for the second quarter 2024”
SPTSprout Social, Inc.
Sprout Social, Inc. reported first quarter ended March 31, 2024 results: revenue $96.8 million, net income GAAP net loss was ($13.6) million, EPS GAAP net loss per share was ($0.24).
“focus around our best customer cohorts will allow us to scale a durable, efficient upmarket land & expand motion.” First Quarter 2024 Financial Highlights Revenue ● Revenue was $96.8 million, up 29% compared to the first quarter of 2023. ● Total remaining performance obligations (RPO) of $290.0 million as of March 31, 2024, up 54% year-over-year. ● Current remaining”
RAREUltragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. reported quarter ended March 31, 2024 results: revenue $109 million, net income net loss of $171 million, or $2.03 per share basic and diluted, EPS $2.03 per share basic and diluted. Guidance reaffirmed.
“Pharmaceutical Inc. Investors Joshua Higa ir@ultragenyx.com Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update First quarter total revenue of $109 million, Crysvita® revenue of $83 million and Dojolvi® revenue of $16 million Reaffirmed 2024 expected total revenue guidance between $500 million to $530 million, Crysvita revenue of”
FDUSFIDUS INVESTMENT Corp
FIDUS INVESTMENT Corp reported the first quarter ended March 31, 2024 results: revenue $34.7 million, net income $17.6 million, EPS $0.57 per share.
“First Quarter 2024 Financial Highlights • Total investment income of $34.7 million • Net investment income of $17.6 million, or $0.57 per share”
CIVITAS RESOURCES, INC.
CIVITAS RESOURCES, INC. reported first quarter 2024 results: revenue $1.3 billion, net income $175.8. Guidance reaffirmed.
“owners, and leading in ESG." First Quarter 2024 Financial and Operating Results Crude oil, natural gas, and natural gas liquids ("NGL") sales for the first quarter of 2024 were $1.3 billion, up 18% from the fourth quarter of 2023. The increase was primarily related to 19% higher sales volumes and slightly lower realized commodity pricing. Crude oil accounted for 81%”
UPLDUpland Software, Inc.
Upland Software, Inc. reported the quarter ended March 31, 2024 results: revenue $70.7 million, net income $96.1 million, EPS $3.37 per share.
“and operating results for the first quarter 2024 and issued guidance for its second quarter and full year of 2024. First Quarter 2024 Financial Highlights • Total revenue was $70.7 million, a decrease of 8% from $77.1 million in the first quarter of 2023. • Subscription and support revenue was $67.1 million, a decrease of 8% from $72.9 million in the first quarter”
FNDFloor & Decor Holdings, Inc.
Floor & Decor Holdings, Inc. reported first quarter of fiscal 2024 results: revenue $1,097.3 million, net income $50.0 million, EPS $0.46.
“Floor & Decor Holdings, Inc. Announces First Quarter Fiscal 2024 Financial Results Net sales of $1,097.3 million decreased 2.2% from the first quarter of fiscal 2023 Comparable store sales decreased 11.6% Diluted earnings per share of $0.46 Opened four new warehouse stores ATLANTA--(BUSINESS WIRE)--May 2, 2024--Floor & Decor Holdings, Inc. (NYSE: FND) (“We,” “Our,” the “Company,” or “Floor & Decor”) announces its financial results for the first quarter of fiscal 2024, which ended March 28, 2024.”
HIIHUNTINGTON INGALLS INDUSTRIES, INC.
HUNTINGTON INGALLS INDUSTRIES, INC. reported the quarter ended March 31, 2024 results: revenue $2.8 billion, net income $153 million, EPS $3.87 diluted earnings per share. Guidance reaffirmed.
“HII Reports First Quarter 2024 Results • Record first quarter revenues of $2.8 billion, up 4.9% compared to first quarter 2023 • Operating income of $154 million, up 9.2% compared to first quarter 2023 • Net earnings of $153 million or $3.87 diluted earnings per share • New contract awards of $3.1 billion, resulting in backlog of $48.4 billion • Company reaffirms previously issued financial guidance”
WDWalker & Dunlop, Inc.
Walker & Dunlop, Inc. reported financial results for the quarter and year-to-date period ended March 31, 2024.
“On May 2, 2024 Walker & Dunlop, Inc. (the “Company”) issued a press release reporting its financial results for the quarter and year-to-date period ended March 31, 2024.”
MTSIMACOM Technology Solutions Holdings, Inc.
MACOM Technology Solutions Holdings, Inc. reported fiscal second quarter ended March 29, 2024 results: revenue $181.2 million, net income $15.0 million, EPS $0.20 per diluted share. Guidance reaffirmed.
“of semiconductor products, t oday announced its financial results for its fiscal second quarter ended March 29, 2024. Second Quarter Fiscal Year 2024 GAAP Results • Revenue was $181.2 million, an increase of 7.0%, compared to $169.4 million in the previous year fiscal second quarter and an increase of 15.3% compared to $157.1 million in the prior fiscal quarter; •”
OFSOFS Capital Corp
OFS Capital Corp reported the quarter ended March 31, 2024 results: revenue $14,233, net income $(9,049), EPS $(0.67).
“respectively, were placed on non-accrual status. RESULTS OF OPERATIONS (unaudited) (in thousands) Three Months Ended March 31, 2024 December 31, 2023 Total investment income $ 14,233 $ 13,483 Expenses: Interest expense 4,572 4,684 Base management and incentive fees 2,922 2,819 Other expenses 1,143 1,284 Total expenses 8,637 8,787 Net investment income 5,596”
IQVIQVIA HOLDINGS INC.
IQVIA HOLDINGS INC. reported first quarter ended March 31, 2024 results: revenue $3,737 million, net income $288 million, EPS $1.56. Guidance reaffirmed.
“as shall be expressly set forth by specific reference to such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 IQVIA Reports First-Quarter 2024 Results • Revenue of $3,737 million • GAAP Net Income of $288 million, Adjusted EBITDA of $862 million • GAAP Diluted Earnings per Share of $1.56, Adjusted Diluted Earnings per Share of $2.54 • R&D Solutions”
NETCloudflare, Inc.
Cloudflare, Inc. reported the fiscal quarter ended March 31, 2024 results: revenue $378.6 million, net income GAAP net loss was $35.5 million, compared to $38.1 million in the first quarter of 2023. GAAP net loss per basic and dil, EPS $0.10.
“loudflare Announces First Quarter 2024 Financial Results • First quarter revenue totaled $378.6 million, representing an increase of 30% year-over-year • GAAP loss from operations of $54.6 million, or 14% of revenue, and non-GAAP income from operations of $42.4 million, or 11% of revenue • Operating cash flow of $73.6 million, or 19% of revenue, and free cash flow of $35.6 million, or 9% of revenue San Francisco, CA, May 2, 2024 — Cloudflare, Inc.”
Eventbrite, Inc.
Eventbrite, Inc. reported the quarter ended March 31, 2024 results: revenue $86.3 million, net income Net loss of $4.5 million.
“Eventbrite Reports First Quarter 2024 Financial Results First quarter revenue of $86.3 million grew 11% year-over-year”
TPICQTPI COMPOSITES, INC
TPI COMPOSITES, INC reported three months ended March 31, 2024 results: revenue $299.1 million, net income -$61.8 million, EPS -$1.31. Guidance reaffirmed.
“Net sales for the three months ended March 31, 2024, decreased 26.0% to $299.1 million as compared to $404.1 million in the same period in 2023 due to the following: Net Sales of wind blades, tooling and other wind related sales (“Wind”) decreased by $98.7 million, or 25.5%, to $288.9 million for the three months ended March 31, 2024, as compared to $387.6 million in the same period in 2023. The decrease was primarily due to a decrease in the number of wind blades produced due to the number of lines that we are starting up or transitioning, expected volume declines based on market activity levels, and lower average sales prices of wind blades due to changes in the mix of wind blade models produced. This decrease was partially offset by favorable foreign currency fluctuations and an increase in tooling sales in preparation for manufacturing line startups and transitions. Automotive sales decreased $5.3 million, or 51.1%, to $5.0 million for the three months ended March 31, 2024, as comp”
2U, Inc.
2U, Inc. reported quarter ended March 31, 2024 results: revenue $198.4 million, net income $54.6 million, EPS $0.65 per share. Guidance reaffirmed.
“improvement initiatives, put us in a strong position to fix our balance sheet.” Results for First Quarter 2024 compared to First Quarter 2023 • Revenue decreased 17% to $198.4 million • Degree Program Segment revenue decreased 21% to $111.5 million • Alternative Credential Segment revenue decreased 11% to $86.8 million • Net loss was $54.6 million, or $0.65”
ABUSArbutus Biopharma Corp
Arbutus Biopharma Corp reported financial results for first quarter ended March 31, 2024.
“On May 2, 2024, Arbutus Biopharma Corporation (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2024 and certain other information.”
CSTLCASTLE BIOSCIENCES INC
CASTLE BIOSCIENCES INC reported the first quarter ended March 31, 2024 results: revenue $73.0 million, net income Net loss... was $2.5 million. Guidance raised.
“such filing to this Current Report on Form 8-K. --- EX-99.1 (EX-99.1) --- Castle Biosciences Reports First Quarter 2024 Results Q1 2024 revenue increased 74% over Q1 2023 to $73 million Q1 2024 total test reports increased 40% over Q1 2023 Raising full-year 2024 revenue guidance to $ 255-265 million from $235-240 million Conference call and webcast today at 4:30”
WKWORKIVA INC
WORKIVA INC reported first quarter ended March 31, 2024 results: revenue Total revenue for the first quarter of 2024 reached $176 million, net income GAAP net loss for the first quarter of 2024 was $12 million, EPS GAAP net loss per basic and diluted share was $0.21. Guidance reaffirmed.
“Workiva Inc. Announces First Quarter 2024 Financial Results • Increased Q1 2024 Subscription & Support Revenue by 20% over Q1 2023 • Total revenues of $176 million in Q1 2024, representing 17% year-over-year growth • Achieved 34% YOY Growth of Customers with Annual Contract Value Over $300K NEW YORK - May 2, 2024 – Workiva Inc. (NYSE:WK), the world’s leading cloud platform for assured integrated reporting, today announced financial results for its first quarter ended March 31, 2024.”
APPNAPPIAN CORP
APPIAN CORP reported the first quarter ended March 31, 2024 results: revenue Total revenue was $149.8 million, net income GAAP net loss was $(32.9) million, EPS GAAP net loss per share was $(0.45).
“increased 19% year-over-year to $117.7 million. Professional services revenue was $32.1 million, a decrease of 11% compared to the first quarter of 2023. Total revenue was $149.8 million, up 11% compared to the first quarter of 2023. Cloud subscription revenue retention rate was 120% as of March 31, 2024. • Operating loss and non-GAAP operating loss: GAAP”
AGIOAGIOS PHARMACEUTICALS, INC.
AGIOS PHARMACEUTICALS, INC. reported the first quarter ended March 31, 2024 results: revenue $8.2 million.
“RISE UP Study in Sickle Cell Disease, ACTIVATE-KIDS and ACTIVATE KIDS-T in Pediatric PK Deficiency, All Expected by End of 2025 – – PYRUKYND® (Mitapivat) Net Revenue of $8.2 Million in Q1; Cash, Cash Equivalents and Marketable Securities of $714.3 Million as of March 31, 2024 – CAMBRIDGE, Mass., May 2, 2024 – Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a”
DMRCDigimarc CORP
Digimarc CORP reported the first quarter ended March 31, 2024 results: revenue $9.9 million, net income $10.3 million, EPS ($0.50) per share.
“compared to $4.0 million for the first quarter of 2023 , primarily reflecting the timing of government program work . Total revenue for the first quarter of 2024 increased to $9.9 million compared to $7.8 million for the first quarter of 2023 . Gross profit margin for the first quarter of 2024 increased to 63% compared to 54% for the first quarter of 2023 .”
BFAMBRIGHT HORIZONS FAMILY SOLUTIONS INC.
BRIGHT HORIZONS FAMILY SOLUTIONS INC. reported fiscal quarter ended March 31, 2024 results: revenue $623 million, net income $17 million, EPS $0.29. Guidance reaffirmed.
“• Revenue of $623 million (increase of 12%) • Income from operations of $40 million (increase of 30%) • Net income of $17 million and diluted earnings per common share of $0.29 (increases of 109% and 107%, respectively)”
FOXFFOX FACTORY HOLDING CORP
FOX FACTORY HOLDING CORP reported first fiscal quarter ended March 29, 2024 results: revenue $333.5 million, net income $3.5 million, EPS $0.08. Guidance lowered.
“Fox Factory’s branded off-road upfitted truck, model year ’25 bike releases and the introduction of side-by-side upfits • Net sales for the first quarter of fiscal 2024 were $333.5 million and in line with expectations • Loss per diluted share for the first quarter of fiscal 2024 was $0.08, and adjusted earnings per diluted share was $0.29 and above our”
ARDXARDELYX, INC.
ARDELYX, INC. reported financial results for first quarter ended March 31, 2024.
“On May 2, 2024, Ardelyx, Inc. (the “Company”) announced its financial results for the quarter ended March 31, 2024.”
KURAKura Oncology, Inc.
Kura Oncology, Inc. reported the first quarter ended March 31, 2024 results: net income Net loss for the first quarter of 2024 was $49.5 million.
“Kura Oncology, Inc. (the "Company") issued a press release announcing the Company's financial results for the first quarter ended March 31, 2024 and providing a corporate update.”
ENOVEnovis CORP
Enovis CORP reported the first quarter ended March 29, 2024 results: revenue $516 million, net income net loss from continuing operations of $72 million, EPS net loss from continuing operations of $1.32 per share and adjusted earnings per diluted share of $0.50. Guidance raised.
“will host an investor conference call and live webcast to discuss these results today at 8:00 am ET. First Quarter 2024 Financial Results Enovis’ first-quarter net sales of $516 million grew 27% on a reported basis and 5% on a proforma basis from the same quarter in 2023. First-quarter results reflect continued execution in P&R, strong growth in Recon, and the”
IDCCInterDigital, Inc.
InterDigital, Inc. reported the quarter ended March 31, 2024 results: revenue $263.5, net income $81.7, EPS $2.88. Guidance reaffirmed.
“Quarter 2024 Financial Highlights, as compared to First Quarter 2023: Three Months Ended March 31, (in millions, except per share data) 2024 2023 Change GAAP Results: Revenues $263.5 $202.4 30% Operating Expenses (a) $159.8 $83.1 92% Net income 1 $81.7 $105.3 (22)% Net income 1 margin 31% 52% (21) ppt Diluted EPS 1 $2.88 $3.58 (20)% Non-GAAP Results: Adjusted”
PBYIPUMA BIOTECHNOLOGY, INC.
PUMA BIOTECHNOLOGY, INC. reported the first quarter ended March 31, 2024 results: revenue $43.8 million, net income net loss of $4.8 million, EPS $0.10 per basic and diluted share.
“sales of NERLYNX, Puma’s first commercial product, license revenue from Puma’s sub-licensees and royalty revenue. For the first quarter ended March 31, 2024, total revenue was $43.8 million, of which $40.3 million was net product revenue and $3.5 million was royalty revenue. This compares to total revenue of $52.8 million in the first quarter of 2023, of which $46.8”
VMCVulcan Materials CO
Vulcan Materials CO updated its first quarter ended March 31, 2024 guidance (reaffirmed).
“On May 2, 2024, Vulcan Materials Company announced its financial results for the first quarter ended March 31, 2024.”
TRGPTarga Resources Corp.
Targa Resources Corp. reported first quarter 2024 results: net income $275.2 million. Guidance reaffirmed.
“First quarter 2024 net income attributable to Targa Resources Corp. was $275.2 million compared to $497.0 million for the first quarter of 2023. The Company reported record adjusted earnings before interest, income taxes, depreciation and amortization, and other non-cash items (“adjusted EBITDA”) (1) of $966.2 million for the first quarter of 2024 compared to $940.6 million for the first quarter of 2023.”
GEVOGevo, Inc.
Gevo, Inc. reported first quarter 2024 results: revenue $4.0 million, EPS $0.08.
“Revenue of $4.0 million for the first quarter includes RNG sales of $0.2 million and $3.8 million of net proceeds from sales of environmental attributes.”
MARIN SOFTWARE INC
MARIN SOFTWARE INC reported the first quarter ended March 31, 2024 results: revenue $4.0 million.
“Growth: A leading Amazon retailer saw a revenue increase of more than 155% through optimized campaign management. First Quarter 2024 Financial Updates: • Net revenues totaled $4.0 million, a year-over-year decrease of 12% when compared to $4.6 million for the first quarter of 2023. • GAAP loss from operations was ($2.5) million, resulting in a GAAP operating”
IRTCiRhythm Holdings, Inc.
iRhythm Holdings, Inc. reported three months ended March 31, 2024 results: revenue $131.9 million, net income $45.7 million, or a diluted loss of $1.47 per share, EPS $1.47 per share. Guidance raised.
“that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2024. First Quarter 2024 Financial Highlights • Revenue of $131.9 million, a 18.4% increase compared to first quarter 2023 • Gross margin of 66.3%, a 160-basis point decline compared to first quarter 2023 • Unrestricted cash, cash equivalents and”
CNKCinemark Holdings, Inc.
Cinemark Holdings, Inc. reported the three months ended March 31, 2024 results: revenue $579 million, net income $25 million, EPS $0.19.
“8-K and incorporated herein by reference. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 CINEMARK HOLDINGS, INC. REPORTS FIRST QUARTER 2024 RESULTS Delivered Total Revenue of $579 million, Net Income of $25 million, and Adjusted EBITDA of $71 million with a 12.2% Adjusted EBITDA margin, demonstrating skillful navigation of dynamic operating environment impacted by”
TRUPTRUPANION, INC.
TRUPANION, INC. reported the first quarter ended March 31, 2024 results: revenue $306.1 million, net income $(6.9) million, or $(0.16) per basic and diluted share, EPS $(0.16) per basic and diluted share.
“generation with the intention of gradually increasing our spending on growth as our margins expand." First Quarter 2024 Financial and Business Highlights • Total revenue was $306.1 million, an increase of 19% compared to the first quarter of 2023. • Total enrolled pets (including pets from our other business segment) was 1,708,017 at March 31, 2024, an increase of”
WLDNWilldan Group, Inc.
Willdan Group, Inc. reported first quarter ended March 29, 2024 results: revenue $122.5 million, net income $2.9 million, EPS $0.21. Guidance reaffirmed.
“in electricity demand from artificial intelligence and data centers is becoming a new catalyst in our market.” First Quarter 2024 Highlights* ● Consolidated contract revenue of $122.5 million, up 19.4%. ● Net revenue** of $68.9 million, up 11.7%. ● Net income of $2.9 million, up from net income of $0.9 million. ● Adjusted EBITDA** of $11.0 million, up 11.7%. ● GAAP”
Enstar Group LTD
Enstar Group LTD reported the quarter ended March 31, 2024 results: net income $119 Million.
“Enstar Group Limited Reports First Quarter 2024 Results • Net Income Attributable to Enstar Ordinary Shareholders of $119 Million; Return on Equity of 2.4% Primarily Driven by Positive Investment Results”
ICFIICF International, Inc.
ICF International, Inc. updated its the first quarter ended March 31, 2024 guidance (reaffirmed).
“On May 2, 2024, ICF International, Inc. (the "Company") announced its financial results for the first quarter ended March 31, 2024.”
WFCFWhere Food Comes From, Inc.
Where Food Comes From, Inc. reported the three month period ended March 31, 2024 results: revenue $5.6 million, net income $178,000, EPS $0.03 per diluted share.
“vs. 2023 ● Verification and certification revenue up 17% to $4.4 million from $3.8 million ● Product sales lower at $0.7 million vs. $1.0 million ● Total revenue increased to $5.6 million from $5.3 million ● Net income increased 47% to $178,000 from $121,000 ● Diluted EPS increased to $0.03 from $0.02 ● Adjusted EBITDA up 8% to $432,000 from $399,000 ● Company”
TARAProtara Therapeutics, Inc.
Protara Therapeutics, Inc. reported financial results for first quarter ended March 31, 2024.
“On May 2, 2024, Protara Therapeutics, Inc. (the "Company") announced its financial results for the quarter ended March 31, 2024 in the press release attached hereto as Exhibit 99.1 and incorporated herein by reference.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.